Survey results published by UCLA on Thursday have revealed that a vast majority of medical professionals in the U.S. consider cannabis treatment to be appropriate for severe cases of epilepsy. The general response from neurologists and epileptologists, however, did not agree with that majority: only 48 percent of such specialists said they would advise the use of medicinal cannabis.
Survey investigators reported 776 responses from participants across North America and Europe.
An 83 percent majority of all physicians, nurses, researchers and other health professionals said that — in the event of severe epilepsy — they would advise medical marijuana treatment. 78 percent of participants agreed that there should be some sort of pharmacological grade CBD compound available as medicine for epilepsy treatment.
More than half of the U.S. has legalized the use of medical marijuana for certain debilitative conditions. Currently, epilepsy is one of the most common conditions for which medical marijuana is prescribed.
Photo Credit: Fotos GOVBA
Get daily cannabis business news updates. Subscribe